Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
143 |
issn |
1421-9786 1015-9770 |
issueIdentifier |
Suppl. 1 |
pageRange |
138-143 |
publicationName |
Cerebrovascular diseases (Basel, Switzerland) |
startingPage |
138 |
bibliographicCitation |
Sherman DG. Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step? Cerebrovasc Dis. 2004;17 Suppl 1():138–43. doi: 10.1159/000074806. PMID: 14694291. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_baff9e1c246e93e6e2cc2ea6652081de |
date |
2003-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1159/000074806 https://pubmed.ncbi.nlm.nih.gov/14694291 |
isPartOf |
https://portal.issn.org/resource/ISSN/1421-9786 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20932 https://portal.issn.org/resource/ISSN/1015-9770 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Antithrombotic and Hypofibrinogenetic Therapy in Acute Ischemic Stroke: What Is the Next Step? |
discusses |
http://id.nlm.nih.gov/mesh/M0008434 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D002545Q000188 http://id.nlm.nih.gov/mesh/D005343Q000627 http://id.nlm.nih.gov/mesh/D020521Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D000208 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6893 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9233 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7559 |